放射性碘治疗对不同分化型甲状腺癌女性卵巢储备影响的纵向分析
研究前瞻性纳入65例计划首次放射性碘(RAI)治疗的分化型甲状腺癌(DTC)女性,中位随访34个月、中位5次抗苗勒管激素(AMH)检测。单次RAI组AMH在12个月内下降55%后稳定,多次RAI组48个月时进一步下降85%;基线年龄显著影响AMH变化,年轻患者下降较缓。
要点
- 单次RAI后AMH在12个月内下降55%,之后保持稳定。
- 多次RAI者在稳定后进一步下降,48个月时降幅达85%。
- 基线年龄显著影响AMH变化,<35岁患者下降较缓。
核心结论
- 在行全甲状腺切除和单次RAI治疗的女性DTC患者中,AMH浓度在初始治疗后第一年内显著下降,之后保持稳定。
- 接受多次RAI治疗的患者可见AMH进一步下降。
- 基线年龄显著影响AMH随时间的变化。
- 这些结果支持当前美国甲状腺协会(ATA)指南所倡导的对低危患者采用较不激进的RAI治疗,尤其是对35岁以上有生育意愿的女性。
研究设计与样本
- 前瞻性研究,纳入在本院计划首次RAI治疗的16岁至绝经前的女性DTC患者。
- 在初始治疗前及之后定期检测血清AMH。
- 采用重复测量分析评估AMH浓度随时间的变化,以及年龄和累积RAI剂量的影响。
- 65例患者获得纵向AMH评估,平均年龄32岁,中位随访34个月,中位检测5次。
主要发现
- AMH浓度随时间呈非线性变化:单次RAI组在12个月内下降55%,之后稳定。
- 多次RAI组在稳定后进一步下降,48个月时降幅达85%。
- 两个RAI组中年龄均显著影响AMH随时间的变化,<35岁患者下降较缓。
临床怎么用
- 作者认为,结果支持当前ATA指南所倡导的对低危患者采用较不激进的RAI治疗,尤其是35岁以上有生育意愿的女性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Although international guidelines have become more conservative on the use of radioactive iodine (RAI) therapy, it is still one of the cornerstones of the treatment of patients with advanced differentiated thyroid cancer (DTC). As a large proportion of females diagnosed with DTC is in their reproductive years, knowledge about the effect of RAI on their gonadal and reproductive function is important. Earlier studies evaluating Anti-Müllerian hormone (AMH) as a representative of ovarian reserve were either cross-sectional, had relatively low numbers, had no patients with multiple RAI therapies, or had a relatively short follow-up. The primary aim of our study was, therefore, to prospectively evaluate the effect of RAI on AMH in women undergoing treatment for DTC. Methods: We included females, aged 16 years until menopause, who were scheduled to undergo their first RAI treatment for DTC at our hospital. Serum AMH was measured before initial therapy and regularly thereafter. Repeated measurement analysis was used to assess the changes of AMH concentrations over time, and how this is influenced by age and cumulative RAI dose. Results: Longitudinal AMH assessments were available in 65 patients (mean age 32 years, median of five measurements during median follow-up of 34 months). AMH concentrations changed nonlinear over time, decreased until 12 months in the single RAI group (-55%), and stabilized thereafter. In the multiple RAI group, after stabilization, a further decrease occurred (-85% after 48 months). Age in both RAI groups significantly influenced AMH change over time, with younger patients (<35 years of age) showing a less steep decrease. Conclusions: In a population of female DTC patients treated with total thyroidectomy and a single RAI therapy, AMH concentrations significantly dropped during the first year after initial therapy, and thereafter they remained stable. In patients receiving multiple RAI therapies, a further decrease was seen. Age at baseline significantly influenced AMH change over time. These results support a less aggressive treatment with RAI in low-risk patients as is advocated in the current American Thyroid Association (ATA) guidelines, especially in females older than 35 years of age with the desire to have a child.
引用
- van Velsen EFS, Visser WE, van den Berg SAA, et al. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer. Thyroid. 2020. PMID: 31928168. doi:10.1089/thy.2019.0504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。